SECONDARY PROGRESSIVE MULTIPLE SCLEROSIS (SPMS)
Clinical trials for SECONDARY PROGRESSIVE MULTIPLE SCLEROSIS (SPMS) explained in plain language.
Never miss a new study
Get alerted when new SECONDARY PROGRESSIVE MULTIPLE SCLEROSIS (SPMS) trials appear
Sign up with your email to follow new studies for SECONDARY PROGRESSIVE MULTIPLE SCLEROSIS (SPMS), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill could slow MS progression in major trial
Disease control Recruiting nowThis Phase 3 study tests whether the drug remibrutinib can slow disability worsening in people with secondary progressive multiple sclerosis (SPMS). About 1,275 adults aged 18-65 with SPMS and recent disability progression will receive either remibrutinib or a placebo. The main g…
Matched conditions: SECONDARY PROGRESSIVE MULTIPLE SCLEROSIS (SPMS)
Phase: PHASE3 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
Could donor cells stop MS progression? early trial launches
Disease control Recruiting nowThis early-stage trial tests a cell therapy called TRX319 in 39 adults with progressive multiple sclerosis (MS). The goal is to see if it is safe and to find the best dose. Participants receive TRX319 infusions, sometimes after a chemotherapy drug called bendamustine, and are fol…
Matched conditions: SECONDARY PROGRESSIVE MULTIPLE SCLEROSIS (SPMS)
Phase: PHASE1, PHASE2 • Sponsor: Tr1X, Inc. • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
Can a cancer drug sharpen the mind and hands in advanced MS?
Disease control Recruiting nowThis study tests whether rituximab, a drug used for certain cancers and autoimmune diseases, can improve thinking and hand function in people with advanced secondary progressive multiple sclerosis (SPMS). About 46 participants with high disability will receive either rituximab or…
Matched conditions: SECONDARY PROGRESSIVE MULTIPLE SCLEROSIS (SPMS)
Phase: PHASE2 • Sponsor: Cairo University • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC